Back

Levels of thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in non-ischemic dilated cardiomyopathy patients with severe left ventricular dysfunction

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic heart failure – Pathophysiology and mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaofei Li

Fuwai Hospital, CAMS and PUMC, Beijing (China)

15 More presentations in this session

Presentation thumbnail
Cardio-renal syndrome type 2: a role of cardiac spinal afferents activation
Professor H. Wang (Omaha, US)
Abstract
Presentation thumbnail
Myocardial proteomic signatures in end-stage dilated and ischemic cardiomyopathy compared with normal human hearts
Professor Z. Zhang (Shanghai, CN)
Abstract
Presentation thumbnail
Rest myocardial blood flow derived from 13N-ammonia positron emission tomography does not differ between stunned and hibernating myocardium in ischemic cardiomyopathy
Doctor D. Benz (Zurich, CH)
Abstract
Presentation thumbnail
Changes in renal proteome induced by presence of chronic congestive heart failure: target identification of cardiorenal syndrome
Doctor V. Melenovsky (Prague, CZ)
Abstract Slides
Presentation thumbnail
Circulating markers of collagen I, III and IV turnover in patients with dilated cardiomyopathy: time-course change and relationships with myocardial collagen expression
Doctor A. Tamura (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic heart failure – Pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources